CNN || Epilepsy & Seizures

FDA: No changes needed in management of ezogabine’s eye and skin effects

Posted on: 16/06/2015 - 18:57

Pigment changes in the retina reported in some patients treated with the antiseizure drug ezogabine do not appear to affect vision, and can be “adequately managed” by following recommendations in the...

Field of Interest: Dermatology

Type: News Item

AAN: Maternal valproate linked to kids’ physical, cognitive problems

Posted on: 30/04/2015 - 20:18

WASHINGTON – One-quarter of valproate-exposed children in an ongoing study had a major birth defect or reduced IQ, Dr. Kimford Meador reported at th... More »

Field of Interest: Pulmonology

Type: News Item

Topiramate

Posted on: 18/11/2014 - 16:23

At Motherisk, we receive increasing numbers of queries from women and clinicians about the use of topiramate during pregnancy, mostly related to its use for...

Field of Interest: Pulmonology

Type: News Item

FDA: No changes needed in management of ezogabine’s eye and skin effects

AAN: Maternal valproate linked to kids’ physical, cognitive problems

Topiramate

Newsletters

Latest Newsletters

You are here

CNN || Epilepsy & Seizures

FDA: No changes needed in management of ezogabine’s eye and skin effects

AAN: Maternal valproate linked to kids’ physical, cognitive problems

Topiramate

Newsletters

Latest Newsletters